Annual Total Liabilities
$27.12 M
-$845.97 M-96.89%
December 31, 2023
Summary
- As of February 7, 2025, NMRA annual total liabilities is $27.12 million, with the most recent change of -$845.97 million (-96.89%) on December 31, 2023.
- During the last 3 years, NMRA annual total liabilities has fallen by -$265.21 million (-90.72%).
- NMRA annual total liabilities is now -96.89% below its all-time high of $873.08 million, reached on December 31, 2022.
Performance
NMRA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$31.80 M
+$8.58 M+36.98%
September 30, 2024
Summary
- As of February 7, 2025, NMRA quarterly total liabilities is $31.80 million, with the most recent change of +$8.58 million (+36.98%) on September 30, 2024.
- Over the past year, NMRA quarterly total liabilities has increased by +$6.13 million (+23.88%).
- NMRA quarterly total liabilities is now -96.36% below its all-time high of $873.49 million, reached on June 30, 2023.
Performance
NMRA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NMRA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -96.9% | +23.9% |
| 3 y3 years | -90.7% | -95.8% |
| 5 y5 years | +10000.0% | -95.8% |
NMRA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -96.9% | at low | -96.4% | +37.0% |
| 5 y | 5-year | -96.9% | >+9999.0% | -96.4% | +37.0% |
| alltime | all time | -96.9% | >+9999.0% | -96.4% | +37.0% |
Neumora Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.80 M(+37.0%) |
| Jun 2024 | - | $23.21 M(-9.6%) |
| Mar 2024 | - | $25.67 M(-5.3%) |
| Dec 2023 | $27.12 M(-96.9%) | $27.12 M(-15.4%) |
| Sep 2023 | - | $32.06 M(-96.3%) |
| Jun 2023 | - | $873.49 M(+0.0%) |
| Dec 2022 | $873.08 M | $873.08 M(+15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $758.29 M(+1.3%) |
| Mar 2022 | - | $748.85 M(-0.8%) |
| Dec 2021 | $754.52 M(+158.1%) | - |
| Dec 2021 | - | $754.52 M(+0.3%) |
| Sep 2021 | - | $752.42 M(+157.4%) |
| Dec 2020 | $292.33 M(>+9900.0%) | $292.33 M |
| Dec 2019 | $21.00 K | - |
FAQ
- What is Neumora Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Neumora Therapeutics?
- What is Neumora Therapeutics annual total liabilities year-on-year change?
- What is Neumora Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly total liabilities year-on-year change?
What is Neumora Therapeutics annual total liabilities?
The current annual total liabilities of NMRA is $27.12 M
What is the all time high annual total liabilities for Neumora Therapeutics?
Neumora Therapeutics all-time high annual total liabilities is $873.08 M
What is Neumora Therapeutics annual total liabilities year-on-year change?
Over the past year, NMRA annual total liabilities has changed by -$845.97 M (-96.89%)
What is Neumora Therapeutics quarterly total liabilities?
The current quarterly total liabilities of NMRA is $31.80 M
What is the all time high quarterly total liabilities for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly total liabilities is $873.49 M
What is Neumora Therapeutics quarterly total liabilities year-on-year change?
Over the past year, NMRA quarterly total liabilities has changed by +$6.13 M (+23.88%)